Business
Optimus Healthcare Services, Inc Signs Letter of Intent to Acquire PainScript
Optimus Healthcare Services, Inc Signs Letter of Intent to Acquire PainScript.
About this update from Optimus Healthcare Services, Inc.
[{"type":"text","content":"NEW YORK, NY / ACCESSWIRE / February 8, 2021 / Between Dandelions, Inc. (OTC PINK: HOPS), to be renamed as Optimus Healthcare Services, announced today that it has signed a non-binding letter of intent (LOI) to acquire AdhereRx, d/b/a PainScript, a SaaS-based, Telehealth/Chronic Care Compliance platform company. Completion of the transaction is subject to, among other things, the completion of due diligence, the negotiation of a definitive agreement providing for the transaction and satisfaction of the conditions negotiated therein. While the parties are working towards finalizing the transaction as soon as possible, there can be no assurance that a definitive agreement will be entered into or that the proposed transaction will be consummated.Kenny Orr, Chair of Optimus Healthcare Services, said today that "…the agreement we reached to acquire PainScript and its platform to provide a more effective chronic care compliance treatment for Substance Use Disorder (SUD) patients is a unique approach that will lead to better compliance, better patient care and better health outcomes. I have followed the PainScript story as it developed from a concept through clinical trials and now as it prepares to enter the commercial markets. I believe PainScript will be a key addition to our portfolio of companies.""With the financial backing of Optimus Healthcare and the synergies available to us as a portfolio company, PainScript will be able to more quickly bring our SaaS telehealth product to physicians and the patients they treat," said Dan Cohen, CEO of PainScript. "The Optimus goal of bringing market-ready MedTech to physicians will lead to lower healthcare costs and improved patient outcomes. We are excited to be joining their team."In addition, Optimus announced today that they will form a telehealth and medication compliance division called Telehealth Adherence and Compliance Technologies (TACT). PainScript shall be a wholly owned subsidiary of TACT.About OptimusOptimus will focus on acquiring controlling interests in healthcare-related businesses. Between Dandelions Inc. will file for a name change to Optimus Healthcare Services, Inc. as soon as possible.Safe Harbor Statement Information in this news release may contain statements about future expectations, plans, prospects or performance of Between Da...